Suppr超能文献

全身精氨酸二甲化与成人肾移植受者的全因死亡率相关。

Whole-body arginine dimethylation is associated with all-cause mortality in adult renal transplant recipients.

机构信息

Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen and University of Groningen, 9700 RB, Groningen, The Netherlands.

Core Unit Proteomics, Institute of Toxicology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.

出版信息

Amino Acids. 2021 Apr;53(4):541-554. doi: 10.1007/s00726-021-02965-1. Epub 2021 Mar 2.

Abstract

Arginine residues in proteins can be singly or doubly methylated post-translationally. Proteolysis of arginine-methylated proteins provides monomethyl arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). ADMA and SDMA are considered cardiovascular risk factors, with the underlying mechanisms being not yet fully understood. SDMA lacks appreciable metabolism and is almost completely eliminated by the kidney, whereas ADMA is extensively metabolized to dimethylamine (DMA), with a minor ADMA fraction of about 10% being excreted unchanged in the urine. Urinary DMA and ADMA are useful measures of whole-body asymmetric arginine-dimethylation, while urinary SDMA serves as a whole-body measure of symmetric arginine-dimethylation. In renal transplant recipients (RTR), we previously found that higher plasma ADMA concentrations and lower urinary ADMA and SDMA concentrations were associated with a higher risk of all-cause mortality. Yet, in this RTR collective, no data were available for urinary DMA. For the present study, we additionally measured the excretion rate of DMA in 24-h collected urine samples of the RTR and of healthy kidney donors in the cohort, with the aim to quantitate whole-body asymmetric (ADMA, DMA) and symmetric (SDMA) arginine-dimethylation. We found that lower DMA excretion rates were associated with higher all-cause mortality, yet not with cardiovascular mortality. In the healthy donors, kidney donation was associated with considerable decreases in ADMA (by - 39%, P < 0.0001) and SDMA (by - 21%, P < 0.0001) excretion rates, yet there was no significant change in DMA (by - 9%, P = 0.226) excretion rate. Our results suggest that protein-arginine dimethylation is altered in RTR compared to healthy kidney donors and that it is pronouncedly shifted from symmetric to asymmetric arginine-dimethylation, with whole-body protein-arginine dimethylation being almost unaffected.

摘要

蛋白质中的精氨酸残基可以在翻译后被单甲基化或双甲基化。精氨酸甲基化蛋白的蛋白水解提供单甲基精氨酸、非对称二甲基精氨酸(ADMA)和对称二甲基精氨酸(SDMA)。ADMA 和 SDMA 被认为是心血管风险因素,但其潜在机制尚未完全了解。SDMA 几乎没有明显的代谢作用,几乎完全被肾脏清除,而 ADMA 则被广泛代谢为二甲胺(DMA),只有约 10%的 ADMA 分数不变地从尿液中排出。尿中 DMA 和 ADMA 是全身不对称精氨酸二甲基化的有用指标,而尿 SDMA 则是全身对称精氨酸二甲基化的指标。在肾移植受者(RTR)中,我们之前发现较高的血浆 ADMA 浓度以及较低的尿 ADMA 和 SDMA 浓度与全因死亡率风险增加相关。然而,在这个 RTR 队列中,没有关于尿 DMA 的数据。在本研究中,我们还测量了 RTR 中 24 小时收集的尿液样本和队列中健康肾脏供体的 DMA 排泄率,目的是定量全身不对称(ADMA、DMA)和对称(SDMA)精氨酸二甲基化。我们发现较低的 DMA 排泄率与全因死亡率增加相关,但与心血管死亡率无关。在健康供体中,肾脏捐献与 ADMA(-39%,P<0.0001)和 SDMA(-21%,P<0.0001)排泄率的显著下降相关,但 DMA(-9%,P=0.226)排泄率没有显著变化。我们的结果表明,与健康肾脏供体相比,RTR 中的蛋白质精氨酸二甲基化发生了改变,并且从对称精氨酸二甲基化明显转变为不对称精氨酸二甲基化,全身蛋白质精氨酸二甲基化几乎没有受到影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/658a/8107162/c40f63530819/726_2021_2965_Sch1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验